Bruno M.D.C. Godinho

2.5k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

Bruno M.D.C. Godinho is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Bruno M.D.C. Godinho has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Bruno M.D.C. Godinho's work include RNA Interference and Gene Delivery (25 papers), Advanced biosensing and bioanalysis techniques (14 papers) and MicroRNA in disease regulation (10 papers). Bruno M.D.C. Godinho is often cited by papers focused on RNA Interference and Gene Delivery (25 papers), Advanced biosensing and bioanalysis techniques (14 papers) and MicroRNA in disease regulation (10 papers). Bruno M.D.C. Godinho collaborates with scholars based in United States, Ireland and Portugal. Bruno M.D.C. Godinho's co-authors include Anastasia Khvorova, Andrew H. Coles, Dimas Echeverria, Reka A. Haraszti, Caitríona M. O’Driscoll, John F. Cryan, Matthew Hassler, Neil Aronin, Julia F. Alterman and Raphael Darcy and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Bruno M.D.C. Godinho

30 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing

2016 406 citations Marie-Cécile Didiot, Lauren M Hall et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bruno M.D.C. Godinho United States	20	1.3k	471	164	156	124	30	1.6k
Julia F. Alterman United States	17	1.3k 1.0×	508 1.1×	161 1.0×	45 0.3×	133 1.1×	27	1.5k
Matthew Hassler United States	18	1.4k 1.1×	530 1.1×	176 1.1×	50 0.3×	124 1.0×	32	1.6k
Reza Mirfakhraie Iran	22	950 0.7×	657 1.4×	162 1.0×	43 0.3×	102 0.8×	152	1.6k
Samuel S. Ng Hong Kong	20	1.0k 0.8×	625 1.3×	175 1.1×	51 0.3×	27 0.2×	27	1.5k
Mei Zhao China	26	1.1k 0.9×	595 1.3×	151 0.9×	67 0.4×	52 0.4×	62	1.7k
David A. Sampson United States	12	371 0.3×	187 0.4×	126 0.8×	135 0.9×	147 1.2×	23	1.1k
Xiao Gao China	23	1.6k 1.2×	1.1k 2.4×	551 3.4×	111 0.7×	15 0.1×	49	2.3k
Tina Davis United States	11	1.0k 0.8×	121 0.3×	160 1.0×	32 0.2×	49 0.4×	20	1.6k
Kei‐ichi Ozaki Japan	24	1.2k 1.0×	154 0.3×	172 1.0×	67 0.4×	10 0.1×	52	1.5k
Fatih Kocabaş Türkiye	16	1.4k 1.1×	430 0.9×	273 1.7×	80 0.5×	5 0.0×	55	2.1k

Countries citing papers authored by Bruno M.D.C. Godinho

Since Specialization

Citations

This map shows the geographic impact of Bruno M.D.C. Godinho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno M.D.C. Godinho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno M.D.C. Godinho more than expected).

Fields of papers citing papers by Bruno M.D.C. Godinho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno M.D.C. Godinho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno M.D.C. Godinho. The network helps show where Bruno M.D.C. Godinho may publish in the future.

Co-authorship network of co-authors of Bruno M.D.C. Godinho

This figure shows the co-authorship network connecting the top 25 collaborators of Bruno M.D.C. Godinho. A scholar is included among the top collaborators of Bruno M.D.C. Godinho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruno M.D.C. Godinho. Bruno M.D.C. Godinho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ferguson, Chantal, Bruno M.D.C. Godinho, Dimas Echeverria, et al.. (2024). A combinatorial approach for achieving CNS-selective RNAi. Nucleic Acids Research. 52(9). 5273–5284. 3 indexed citations

Abraham, Neeta A., Nadine F. Joseph, Sarah Geisler, et al.. (2024). Dose-dependent reduction of somatic expansions but not Htt aggregates by di-valent siRNA-mediated silencing of MSH3 in HdhQ111 mice. Scientific Reports. 14(1). 2061–2061. 5 indexed citations

Godinho, Bruno M.D.C., Emily G. Knox, James W. Gilbert, et al.. (2022). PK-modifying anchors significantly alter clearance kinetics, tissue distribution, and efficacy of therapeutics siRNAs. Molecular Therapy — Nucleic Acids. 29. 116–132. 16 indexed citations

Kennedy, Zachary, James W. Gilbert, & Bruno M.D.C. Godinho. (2022). Intrathecal Delivery of Therapeutic Oligonucleotides for Potent Modulation of Gene Expression in the Central Nervous System. Methods in molecular biology. 2434. 345–353. 1 indexed citations

Ferguson, Chantal, Bruno M.D.C. Godinho, Julia F. Alterman, et al.. (2021). Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheep. JCI Insight. 6(24). 15 indexed citations

Osborn, Maire F., Andrew H. Coles, Annabelle Biscans, et al.. (2018). Hydrophobicity drives the systemic distribution of lipid-conjugated siRNAs via lipid transport pathways. Nucleic Acids Research. 47(3). 1070–1081. 96 indexed citations

Hassler, Matthew, Anton A. Turanov, Julia F. Alterman, et al.. (2018). Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo. Nucleic Acids Research. 46(5). 2185–2196. 131 indexed citations

Turanov, Anton A., Agnes S. Lo, Matthew Hassler, et al.. (2018). RNAi modulation of placental sFLT1 for the treatment of preeclampsia. Nature Biotechnology. 36(12). 1164–1173. 143 indexed citations

Didiot, Marie-Cécile, Lauren M Hall, Andrew H. Coles, et al.. (2016). Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing. Molecular Therapy. 24(10). 1836–1847. 406 indexed citations breakdown →

10.

Nikan, Mehran, Maire F. Osborn, Andrew H. Coles, et al.. (2016). Docosahexaenoic Acid Conjugation Enhances Distribution and Safety of siRNA upon Local Administration in Mouse Brain. Molecular Therapy — Nucleic Acids. 5(8). e344–e344. 63 indexed citations

11.

Malhotra, Meenakshi, et al.. (2015). RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies. Molecular BioSystems. 11(10). 2635–2657. 7 indexed citations

12.

Coles, Andrew H., Maire F. Osborn, Julia F. Alterman, et al.. (2015). A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo. Nucleic Acid Therapeutics. 26(2). 86–92. 31 indexed citations

13.

Malhotra, Meenakshi, David McCarthy, Bruno M.D.C. Godinho, et al.. (2015). Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: In vitro analysis. European Journal of Pharmaceutical Sciences. 71. 80–92. 62 indexed citations

14.

Godinho, Bruno M.D.C., Julien Ogier, Aoife Quinlan, et al.. (2014). PEGylated cyclodextrins as novel siRNA nanosystems: Correlations between polyethylene glycol length and nanoparticle stability. International Journal of Pharmaceutics. 473(1-2). 105–112. 45 indexed citations

15.

Godinho, Bruno M.D.C., Meenakshi Malhotra, Caitríona M. O’Driscoll, & John F. Cryan. (2014). Delivering a disease-modifying treatment for Huntington's disease. Drug Discovery Today. 20(1). 50–64. 38 indexed citations

16.

Godinho, Bruno M.D.C., David McCarthy, Cristina Torres‐Fuentes, et al.. (2013). Differential nanotoxicological and neuroinflammatory liabilities of non-viral vectors for RNA interference in the central nervous system. Biomaterials. 35(1). 489–499. 35 indexed citations

17.

O’Mahony, Aoife, Bruno M.D.C. Godinho, John F. Cryan, & Caitríona M. O’Driscoll. (2013). Non-Viral Nanosystems for Gene and Small Interfering RNA Delivery to the Central Nervous System: Formulating the Solution. Journal of Pharmaceutical Sciences. 102(10). 3469–3484. 42 indexed citations

18.

Godinho, Bruno M.D.C., Julien Ogier, Raphael Darcy, Caitríona M. O’Driscoll, & John F. Cryan. (2012). Self-assembling Modified β-Cyclodextrin Nanoparticles as Neuronal siRNA Delivery Vectors: Focus on Huntington’s Disease. Molecular Pharmaceutics. 10(2). 640–649. 102 indexed citations

19.

O’Mahony, Aoife, Martin O’Neill, Bruno M.D.C. Godinho, et al.. (2012). Cyclodextrins for Non-Viral Gene and siRNA Delivery. Pharmaceutical Nanotechnology. 1(1). 6–14. 2 indexed citations

20.

Flores‐Muñoz, Mónica, Bruno M.D.C. Godinho, Abdulaziz Almalik, & Stuart A. Nicklin. (2012). Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor. PLoS ONE. 7(9). e45564–e45564. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact